Safety
Cannabis for ADHD in Australia — What the Evidence Says in 2026
Can medicinal cannabis help ADHD? A balanced guide for Australians — what the research shows about CBD and THC for attention and focus, the real risks, and how to access a prescription legally in 2026.
Attention-deficit/hyperactivity disorder (ADHD) affects an estimated 1.2 million Australians across all ages — approximately 7–10% of children and 2–5% of adults. Characterised by difficulties with attention, impulse control, hyperactivity (in some presentations), emotional dysregulation and executive function, ADHD has profound effects on education, employment and relationships.
While stimulant medications (methylphenidate, dexamphetamine, lisdexamfetamine) are effective for the majority of people with ADHD, a significant proportion experience inadequate response, intolerable side effects, or have conditions where stimulants are contraindicated. It is in this context — as well as among the substantial number of adults with ADHD who self-medicate with cannabis — that interest in medicinal cannabis for ADHD has grown.
This guide gives an honest assessment of what the evidence shows, which scenarios cannabis is most and least appropriate for, and how to access legal treatment in Australia. We will not oversell what the evidence supports — ADHD is one of the more complex and nuanced areas in medicinal cannabis.
What the evidence shows — and doesn’t show
Let’s be direct about where the evidence stands.
The honest evidence picture:
There are no large, well-designed, randomised controlled trials demonstrating that cannabis treats ADHD symptoms as a primary indication. The existing evidence base is composed of:
- Self-report surveys showing high rates of cannabis use among adults with ADHD, with many reporting subjective benefit
- Two small observational/open-label studies showing modest symptomatic improvement
- Animal model data suggesting ECS involvement in attention regulation
- Retrospective analyses
This is a substantially weaker evidence base than for conditions like MS spasticity, PTSD nightmares or epilepsy. This does not mean cannabis cannot help people with ADHD — many clearly experience subjective benefit — but the benefit has not been clinically proven to the standard we expect for primary treatment recommendations.
What the available studies show:
2020 European Psychiatry study: 59 adults with ADHD who used medicinal cannabis were evaluated. Self-reported hyperactivity/impulsivity and inattention improved significantly; sleep and anxiety improved substantially. However, the open-label design without placebo control means we cannot rule out placebo effect or the self-selection of patients who responded positively.
2021 Journal of Attention Disorders: A large online survey of ADHD adults found cannabis use was common, and users reported using it primarily for managing emotional dysregulation, sleep and anxiety — not primarily for focus or attention. This aligns with the clinical picture: cannabis may be more relevant for ADHD comorbidities than for core attention symptoms.
Self-medication data: Multiple surveys consistently find adults with ADHD are 2–3x more likely to use cannabis than the general population, and report using it to manage anxiety, emotional dysregulation, restlessness and sleep — symptoms that conventional ADHD medications do not always adequately address.
Where cannabis may genuinely help in ADHD
The clearest evidence for cannabis in ADHD is for comorbid symptoms rather than core attention deficits.
Anxiety and emotional dysregulation
Up to 50% of adults with ADHD have a co-occurring anxiety disorder. Emotional dysregulation — rejection sensitivity, frustration intolerance, rapid mood shifts — is also a hallmark of adult ADHD that responds poorly to stimulant medications. CBD’s well-evidenced anxiolytic effects directly address these dimensions of ADHD experience. Read our full anxiety guide.
Sleep
Sleep disruption is present in up to 75% of people with ADHD — both due to ADHD itself (difficulty “switching off” the mind, delayed sleep phase) and as a side effect of stimulant medications that can interfere with sleep onset. Cannabis — particularly CBD at night and low-dose THC for sleep onset — addresses this directly. Improved sleep consistently produces downstream improvements in daytime attention and emotional regulation. Read our sleep guide.
Restlessness and hyperactivity
Some people with ADHD report that low-dose THC reduces the internal sense of restlessness and physical hyperactivity — the “motor running” quality that adults with ADHD often describe. This is plausible via CB1-mediated reduction of dopaminergic overactivation in motor circuits, but the clinical evidence is very limited.
Core attention symptoms
This is where the picture is most uncertain. Some ADHD adults report that cannabis allows them to focus on tasks of interest more deeply. Others find it severely impairs sustained attention and working memory. The variation is substantial and likely depends on THC dose, individual ECS genotype, and the nature of the attention task.
Low-dose THC (under 5mg) may help some individuals with focus; moderate-to-high doses reliably worsen attention and working memory. If exploring cannabis for attention specifically, start at 1–2.5mg THC and assess carefully.
The risks — which are higher in ADHD
Before prescribing cannabis for ADHD, responsible clinicians weigh the risks that are elevated in this population:
Cannabis use disorder: People with ADHD have 2–3x higher rates of substance use disorders than the general population, including cannabis use disorder. Regular THC use carries a genuine risk of dependence, and the self-regulatory difficulties characteristic of ADHD may make moderation harder. This does not preclude cannabis use but makes prescriber oversight and structured treatment particularly important.
Cognitive impact: THC impairs working memory, processing speed and sustained attention — the exact executive functions most affected by ADHD. Regular high-dose THC use in ADHD is likely to compound these deficits. This is a real concern that distinguishes cannabis for ADHD from cannabis for pain, sleep or spasticity, where cognitive risks are more manageable.
Early-onset ADHD and brain development: Young adults (18–25) with ADHD whose brains are still developing face greater risk from regular THC exposure than older adults. CBD-dominant or CBD-only products are much safer in this age range. Pure THC products are generally not recommended for this group.
Interaction with stimulant medication: Combined cannabis and stimulant medication use is common. At low doses, the combination is generally tolerated. At higher THC doses, the stimulant-THC interaction can increase cardiovascular stress (heart rate, blood pressure). Monitor carefully and disclose to your prescriber.
CBD vs THC for ADHD: the practical guide
| CBD | Low-dose THC (1–5mg) | Moderate-to-high THC (>10mg) | |
|---|---|---|---|
| Anxiety | Strong benefit | Mild benefit at low doses | Risk of worsening |
| Emotional dysregulation | Good benefit via anxiolysis | Variable | Likely worsens |
| Sleep | Good at high doses | Helpful — reduces sleep onset | Helpful for sleep onset; may impair quality long-term |
| Core attention | No direct effect | Possible modest benefit | Reliably worsens |
| Hyperactivity/restlessness | Mild via anxiolysis | Possible benefit | Variable |
| Cognitive function | Neutral | Mild temporary impairment | Significant impairment |
| Risk of misuse | Very low | Moderate | High in ADHD population |
Practical recommendation for ADHD: CBD-dominant products are most appropriate as a starting point for managing ADHD-associated anxiety, emotional dysregulation and sleep. THC, if used, should be kept at the lowest effective dose and used primarily at night for sleep, not during the day for attention or focus.
How cannabis interacts with ADHD medications
If you are taking prescription stimulant medication for ADHD, this is an important conversation to have with your prescriber before adding cannabis.
Methylphenidate (Ritalin, Concerta): No significant pharmacokinetic interaction with CBD. THC can increase heart rate, which may compound stimulant-induced tachycardia at higher doses. Monitor heart rate.
Dexamphetamine / lisdexamfetamine (Vyvanse): Similar to methylphenidate. The combination is commonly used by adults with ADHD — cannabis for evening/weekend symptom management, stimulants for work/study. Monitor cardiovascular effects.
Atomoxetine (Strattera): CBD may raise atomoxetine blood levels via CYP2D6 inhibition — monitor for increased atomoxetine side effects (nausea, heart rate, blood pressure). Discuss with your prescriber.
Guanfacine (Intuniv): Additive sedative effects possible with THC. Use with caution; avoid combining with high THC doses.
A note on children and adolescents with ADHD
Cannabis is not appropriate for children or adolescents with ADHD. This position is consistent across Australian medical authorities, including the TGA, RACGP and ADHD Australia.
The developing brain is significantly more vulnerable to THC’s long-term effects, including on the dopaminergic systems that are already altered in ADHD. Studies consistently show that regular cannabis use in adolescence worsens attention, working memory and impulse control over time — the opposite of what ADHD management aims to achieve.
For children and adolescents with ADHD, the evidence-supported treatments are: stimulant medication, non-stimulant medication (atomoxetine, guanfacine), CBT/coaching, and educational support.
How to access medicinal cannabis for ADHD in Australia
ADHD is not listed as a primary indication for medicinal cannabis in any Australian clinical guideline. However, cannabis can be legally prescribed for ADHD under the TGA’s SAS-B framework, and many Australian GPs and telehealth platforms do prescribe for this indication.
Most common prescribing approach: The prescriber addresses the most clearly evidenced comorbid symptoms — anxiety, sleep disruption, emotional dysregulation — rather than prescribing specifically “for ADHD.” This is clinically honest and still provides meaningful symptom relief.
Step 1: Speak to your GP or a telehealth platform (Alternaleaf, Polln, Leafio). Bring your ADHD diagnosis, current medications and a clear description of which symptoms — specifically: anxiety, sleep, mood/emotional regulation — you are hoping to address with cannabis.
Step 2: Be honest about your cannabis history. If you already self-medicate with cannabis, tell your prescriber — this is important safety information and will not result in your prescription being refused.
Step 3: Your prescriber will most likely recommend a CBD-dominant starting product. They will establish a monitoring schedule, including assessments of both ADHD symptoms and any signs of increased cannabis use disorder risk.
If you are on stimulant medication for ADHD: Do not stop your stimulant medication to replace it with cannabis. Cannabis is not a substitute for stimulant medication in ADHD treatment. The most common approach is to use cannabis as an adjunct — addressing anxiety, sleep and emotional regulation — while maintaining stimulant medication for attention and executive function during work and study hours.
Frequently asked questions
Is medicinal cannabis approved for ADHD in Australia? There is no formal TGA approval or clinical guideline endorsement of cannabis for ADHD. However, cannabis can be legally prescribed for ADHD-associated symptoms (anxiety, sleep, emotional dysregulation) under the TGA’s SAS-B framework by any registered GP.
Does cannabis help with ADHD focus? The evidence is very limited and highly individual. Some adults with ADHD report low-dose THC improves focus; most clinical data suggests moderate-to-high THC impairs the working memory and sustained attention already affected by ADHD. CBD has no direct evidence for improving attention. If exploring this, use the lowest possible THC dose (1–2.5mg) and assess carefully.
Is CBD safe for adults with ADHD? CBD is generally well-tolerated and has a low risk profile. For adults with ADHD specifically, CBD is the safer cannabinoid — it does not impair cognitive function, has a low misuse potential, and directly addresses anxiety and emotional dysregulation, two major ADHD comorbidities. Starting with CBD-dominant products is the recommended approach.
Can teenagers with ADHD use cannabis? No. Cannabis is not appropriate for people under 18 with ADHD. The developing brain is significantly more vulnerable to THC’s effects on attention, memory and dopaminergic systems — compounding rather than helping ADHD. This applies to CBD as well; paediatric medicinal cannabis requires specialist oversight for specific, evidence-supported indications like epilepsy.
Will cannabis affect my stimulant medication? At typical medicinal cannabis doses, the interaction is generally manageable. CBD may slightly raise atomoxetine blood levels. THC may compound stimulant-related tachycardia at high doses. Always disclose cannabis use to your ADHD prescriber and monitor your heart rate if combining with stimulants.
Can cannabis replace ADHD medication? No — cannabis is not a replacement for stimulant medication in ADHD. Stimulants (methylphenidate, dexamphetamine, lisdexamfetamine) are among the most extensively studied and effective treatments in psychiatry. Cannabis addresses comorbid symptoms — particularly anxiety, sleep and emotional dysregulation — not core attention deficits. The two can complement each other as part of a broader ADHD management plan.
Am I at higher risk of cannabis addiction if I have ADHD? Yes — honestly, yes. ADHD is associated with higher rates of substance use disorders, including cannabis use disorder. This does not mean people with ADHD cannot use cannabis responsibly, but it does mean prescriber oversight, dose discipline and regular review are particularly important. If you notice your cannabis use escalating beyond what your prescription specifies, discuss this with your prescriber.